Focus: Wicab is a mid-cap medical device company specializing in sensory substitution technology, transforming neural signals into tactile feedback to restore function in blind and vestibular-impaired patients. With 1,001-5,000 employees and headquarters in Fitchburg, WI, the company operates as a public entity focused on niche high-impact neurological indications.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Wicab to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Flagship sensory substitution device leveraging electrotactile feedback to enable spatial perception in blind patients; represents core commercialization proof of concept.
Help build intelligence for Wicab
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Wicab's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Addresses balance and fall-risk reduction in patients with vestibular dysfunction post-stroke; dual-indication utility broadens addressable market.
Earlier-generation vision restoration device; likely being transitioned toward BrainPort Vision Pro as the premium offering.
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo